Morbid Obesity Due to Prolactinoma and Significant Weight Loss After Dopamine Agonist Treatment. [PDF]
AACE Clin Case Rep, 2021 Ali M, Mirza L.
europepmc +1 more source
Distinct Residues in the Carboxyl Tail Mediate Agonist-induced Desensitization and Internalization of the Human Dopamine D1 Receptor [PDF]
, 2002 Michael Lamey +6 more
openalex +1 more source
Delayed Dopamine Agonist Withdrawal Syndrome After Deep Brain Stimulation for Parkinson Disease. [PDF]
Neurol Clin Pract, 2021 Jackowiak EM +4 more
europepmc +1 more source
Commentary: Clinical characteristics of male prolactinoma patients mainly presenting with severe obesity and the metabolic response to dopamine agonist therapy. [PDF]
Front Endocrinol (Lausanne)Andereggen L, Christ E.
europepmc +1 more source
The early treatment of Parkinson's disease: levodopa, dopamine agonists or both
, 2000 M. B. Stern
openalex +1 more source
(+)‐Dinapsoline: An Efficient Synthesis and Pharmacological Profile of a Novel Dopamine Agonist. [PDF]
, 2002 Sing‐Yuen Sit, NULL AUTHOR_ID
openalex +1 more source
Dopamine Agonist-Associated Hiccup in Parkinson's Disease: A Case Report. [PDF]
Noro Psikiyatr Ars, 2021 Emekli AS, Hanagasi HA.
europepmc +1 more source
A rationale for dopamine agonists as primary therapy for Parkinson's disease.
, 1992 C. Warren Olanow
openalex
In Vivo Evidence that 5-HT2C Receptor Antagonist but not Agonist Modulates Cocaine-Induced Dopamine Outflow in the Rat Nucleus Accumbens and Striatum [PDF]
, 2003 Sylvia Navailles +3 more
openalex +1 more source